T1	Outcomes 455 468	CD19+ B cells
T2	Outcomes 628 641	CD19+ B cells
T3	Outcomes 1075 1088	CD19+ B cells
T4	Outcomes 1178 1214	levels of circulating CD19+ B cells.
T5	Outcomes 1228 1256	total CD19+ blood population
T6	Outcomes 1363 1380	CD19+ blood cells
T7	Outcomes 1609 1622	CD19+ B cells
T8	Outcomes 1742 1760	CD19+ B-cell level
T9	Outcomes 1795 1813	clinical stage III
T10	Outcomes 1905 1915	CD19 cells
T11	Outcomes 1920 1943	longer overall survival
T12	Outcomes 1975 1986	CD19 levels
T13	Outcomes 2033 2053	event-free survival.
T14	Outcomes 2114 2125	CD19 values
T15	Outcomes 2211 2249	number of deaths related to infections
T16	Outcomes 2532 2554	levels of CD19+ cells.
T17	Outcomes 2574 2591	CD19+ cell levels
T18	Outcomes 2747 2768	blood levels of CD19+
T19	Outcomes 2822 2832	CD19+ cell
